Trinity Biotech plc
TRIB
$0.94
$0.022.51%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 09/30/2023 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 11.69% | -208.22% | -12.84% | 24.86% | -777.14% |
| Total Depreciation and Amortization | 329.41% | -7.39% | -68.39% | -69.22% | -4.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.29% | 349.73% | 60.92% | -52.37% | 533.55% |
| Change in Net Operating Assets | -37.40% | 180.36% | 229.47% | -1,620.92% | 108.61% |
| Cash from Operations | -55.18% | 1,284.30% | 75.10% | -789.94% | -60.16% |
| Capital Expenditure | 48.61% | 37.20% | 52.32% | 60.12% | -17.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.67% | -302.34% | -649.39% | 24.43% | 40.51% |
| Cash from Investing | 37.92% | -207.07% | -111.37% | 33.08% | 32.41% |
| Total Debt Issued | -69.23% | -- | 4,321.09% | -- | -- |
| Total Debt Repaid | -31.51% | -19.82% | 94.33% | 16.52% | 5.79% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.01% | 93.79% | 33.13% | -10.19% | -- |
| Cash from Financing | -71.22% | 202.38% | 129.10% | -2.49% | -226.72% |
| Foreign Exchange rate Adjustments | 124.07% | 41.77% | -225.58% | 107.82% | -16.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -449.02% | 190.54% | -104.56% | -149.05% | -180.12% |